Mehmet Can UĞUR, Cengiz CEYLAN, Yalçın KOÇYİĞİT

COVİD-19 HASTALARINDA BİLGİSAYARLI TOMOGRAFİ TUTULUM SKORUNUN KLİNİK VE LABORATUVAR BULGULARLA İLİŞKİSİ

Giriş: Koronavirüs hastalığı-2019 (COVID-19)’un toraks bilgisayarlı tomografi (BT) bulgularının şiddetini belirlemek ve standardize etmek için farklı BT skorlama sistemleri geliştirilmiştir. Çalışmamızda BT ile saptanan COVID-19 pnömonisinin şiddeti ile hastaların klinik ve laboratuvar özellikleri arasındaki ilişkiyi araştırmayı amaçladık. Gereç ve Yöntem: COVID-19 enfeksiyonu nedeniyle yatarak veya ayakta tedavi edilen hastaların verileri geriye dönük olarak değerlendirildi. Hastalar hafif, orta ve şiddetli BT skoru olan hastalar olarak 3 gruba ayrılarak analiz edildi. Bulgular: 53 hasta yatarak, 84 hasta ayakta tedavi edildi. 137 hastanın 82'si hafif, 31'i orta ve 24'ü ağır BT skoruna sahipti. Medyan takip süresi 9 gündü. Grupların yaş, nabız, oksijen satürasyon değerleri, AST, ferritin, CRP ve D-dimer değerleri arasındaki fark istatistiksel olarak anlamlıydı. Sonuç: Uygulanması basit BT skorlama sistemleri COVID-19 enfeksiyonunun klinik seyri ile koreledir ve klinik uygulamada kullanılabilir.

CORRELATION OF COMPUTERIZED TOMOGRAPHY SEVERITY SCORE IN COVID-19 PATIENTS WITH CLINICAL AND LABORATORY RESULTS

Introduction: Different computed tomography CT scoring systems have been developed to determine the severity of coronavirus disease 2019 (COVID-19) thoracic CT findings and standardize them. In our study, we aimed to investigate the relationship between the severity of COVID-19 pneumonia detected by CT and the clinical and laboratory characteristics of the patients. Material and Method: The data of the inpatient or outpatient patients treated due to COVID-19 infection were evaluated retrospectively. The patients were divided into 3 groups as patients with mild, moderate, and severe CT scores. Results: 53 patients were treated as inpatients while 84 patients were treated as outpatients. 82 of 137 patients had mild, 31 of them had moderate, and 24 of them had severe CT scores. Median follow-up was 9 days. The difference between age, pulse, oxygen saturation values, AST, ferritin, CRP and D-dimer values of the groups was statistically significant. Conclusion:In conclusion, simple to apply CT scoring systems correlate with the clinical course of COVID-19 infection and can be used in clinical practice.

PDF

___

1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020 15; 395(10223):470-3.
2. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25(3): 2000045.
3. Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for Typical Coronavirus Disease 2019 (COVID-19)
pneumonia: relationship to negative RT-PCR testing. Radiology 2020; 296(2): E41-5. 4. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology 2020; 296(2): E115-7.
5. Wasilewski PG, Mruk B, Mazur S, Półtorak-Szymczak G, Sklinda K, Walecki J. COVID-19 severity scoring systems in radiological imaging - a review. Pol J Radiol. 2020 17; 85: e361-8.
6. Liu N, He G, Yang X, Chen J, Wu J, Ma M et al. Dynamic changes of Chest CT follow-up in Coronavirus Disease-19 (COVID-19) pneumonia: relationship to clinical typing. BMC Med Imaging 2020 5; 20(1): 92.
7. Yang R, Li X, Liu H, Zhen Y, Zhang X, Xiong Q, et al. Chest CT severity score: An ımaging tool for assessing severe COVID-19. J Thorac Imaging 2020;2(2): e200047.
8. Rubin EJ, Harrington DP, Hogan JW, Gatsonis C, Baden LR, Hamel MB. The urgency of care during the Covid-19 pandemic - learning as we go. N Engl J Med 2020 18; 382(25): 2461-2.
9. Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol 2020; 30(12): 6808-17.
10. Li K, Wu J, Wu F, Guo D, Chen L, Fang Z et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol 2020; 55(6): 327-31.
11. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: A multicenter study. AJR Am J Roentgenol 2020; 214(5): 1072-7.
12. Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: A meta-analysis. Nicotine Tob Res 2020 24; 22(9): 1653-6.
13. Pimentel MAF, Redfern OC, Hatch R, Young JD, Tarassenko L, Watkinson PJ. Trajectories of vital signs in patients with COVID-19. Resuscitation. 2020; 156:99-106.
14. Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med 2020; 25; 58(7): 1063-9.
15. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020 30; 382(18): 1708-20.
16. Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta 2020; 510: 475-82.
17. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18(4): 844-7.
18. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ et al. Clinical characteristics of 140 patients infected with SARSCoV-2 in Wuhan, China. Allergy 2020; 75(7): 1730-41.
19. Yuan J, Zou R, Zeng L, Kou S, Lan J, Li X et al. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflamm Res 2020; 69(6): 599-606.
20. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl) 2020 5; 133(9): 1032-8.